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Resumen 
 
Las tecnologías de secuenciación han sufrido mejoras en su desempeño en los últimos años. La 
secuenciación de próxima generación se está utilizando con más frecuencia para controlar 
enfermedades infecciosas, para conocer y anticipar la resistencia antimicrobiana (AMR) y en los 
controles de vigilancia contra posibles brotes infecciosos. Los ensayos moleculares utilizados 
para detectar agentes patógenos o resistentes a los antibióticos requieren mucho tiempo y 
esfuerzo, y a menudo no se recopila suficiente información para tomar decisiones. La 
secuenciación de próxima generación parece dilucidar en el menor tiempo posible toda la 
secuencia de ADN y nos proporciona datos suficientes para conocer la resistencia, la virulencia 
y la tipificación que se pueden analizar y una gran ayuda en la investigación y la toma de 
decisiones. NGS es una tecnología muy prometedora, para que se use ampliamente, requiere el 
desarrollo de plataformas de análisis de datos y la reducción de los costos de prueba que aún es 
muy alta para un uso masivo. 
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Abstract 
 
Sequencing technologies have suffered over the last few years improvements in its performance, 
Next-generation Sequencing is being used more frequently to control infectious diseases, to know 
and anticipate antimicrobial resistance (AMR) and in surveillance controls against possible 
infectious outbreaks. Molecular assays used to detect pathogenic or antibiotic resistant agents 
take a lot of time and effort, and often enough information is not collected to make decisions. 
Next- generation sequencing appears to elucidate in the least time possible the whole DNA 
sequence and provide us with enough data to know resistance, virulence and typing that can be 
analyzed and a great help in research and decision making. NGS is a very promising technology, 
in order for it to be used extensively, requires the development of data analysis platforms and 
reduction of trials costs that still is very high for a massive use. 
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1. Introduction 
 
Development of Antimicrobial Resistance (AMR) 
Antimicrobial Resistance is one of the greatest threats to public health worldwide, current data 
indicate that AMR produces close to 700 000 deaths per year, and it is estimated that by the year 
2050 this figure will reach 10 million if measurements and strategies are not taken to face it (Otto, 
2017).  
 
Antibiotics have been used since the twentieth century and it caused a great impact in the battle 
against diseases, without them millions of lives would have been lost and humanity as we know 
it today would not exist. The antibiotics have the property of killing or inhibiting bacterial growth 
without causing greater damage to the cells that are their receptors or to the tissues that surround 
them. Antibiotics are the most prescribed drugs by doctors with 70 million doses administered by 
2010, increasing by 36% in consumption compared to 2000 (Crofts, et al., 2017).  Antibiotics have 
been produced in nature since ancient times, they can be found in the environment, and therefore, 
resistance to these antibiotics have also been produced naturally by microorganisms from the 
environment. Even genes resistant to some antibiotics currently used have been found in 
permafrost preserved for thousands of years out of the reach of humans. There is evidence that 
the increase of genes resistant to antibiotics in soil samples have been caused by indiscriminate 
use in health, agriculture and industry. Worldwide, AMRs with a high death rate are those related 
to malaria, tuberculosis and HIV, while in the developed countries hospital infections related to 
methicillin resistant Staphylococcus Aureus (MRSA) and Enterobacteriaceae beta- lactam are the 
most recurrent problems (Otto, 2017). Advances in the DNA sequence have brought the 
possibility of monitoring AMR epidemiology with much detail that was previously impossible to 
perform. 
 
Next Generation Technologies 
NGS is a tool that in the future will replace the traditional microbiological methods that are used 
for the analysis of pathogens. The development of faster tools for the DNA sequence came with 
the Human Genome Project in 1990, in which more advanced technologies were needed to 
comply with the genome analysis. 
 
There are three kinds of sequencers, the ¨first- generation¨ was Sanger Method. The Sanger 
sequencing produces long (500-1000 bp) high quality DNA sequences (Besser et al., 2018) , but 
it takes a long time to get the results. In 2005 appeared the NGS that allowed the DNA sequence 
with millions sequences read in a single run, this was called second-generation sequencing. 
Different sequencers have been developed and allow the analysis of short (500-400 bp) or long 
(1-100 kb) reads, among them those who dominate the market are Illumina and ThermoFisher 
sequencers. There is a third- generation of sequencers that can generate large fragments (>200 
kb), which offers fast sequence runs and long reads. Among them is Sequel (Pacific Biosciences) 
that can provide the identity and the whole genome sequence of a pathogen, but it has low 
accuracy. MinION (Oxford Nanopore), is a portable device with little consumption of instruments 
and consumables, which makes cost-efficient. The third generation of sequencers is not yet used 
in laboratories due to their low throughput and high cost (Deuremberg et al., 2017; Quainoo et 
al., 2017).  
 
Although NGS has different technologies, the steps to be taken to obtain the whole genome of an 
organism are shown in Figure 1. 
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Fig.1. Next generation sequencing workflow 
 
 
NGS to control the antibiotic resistance emerging in clinics 
NGS plays an important role in outbreaks infections in hospitals or clinics, helps to elucidate the 
pathogen that causes the infection and how it is transmitted between patients. This technology 
was useful in University Medical Center Groningen, Netherlands, where CTX-M-15 producing 
Klebsiella pneumoniae were transmitted   between patients from a center and after to the whole 
institution, using NGS was detected K.pneumoniae, high-risk-clone (HiRic) in the shortest 
possible time and control measures were taken to avoid the dissemination (Zhou et al., 2016). 
 
Harris et al. (2013) made an investigation of an MRSA outbreak occurred in a children's unit, 
where a patient was infected with the same outbreak strain of an MRSA-positive patient who left 
the unit 64 days earlier, using WGS was confirmed that MRSA strain was the same as the 
previous outbreak. The staff members were screened and a member was identified as a carrier 
of MRSA, a quick analysis with NGS identified that MRSA strain was the same as the infected 
patient. Consequently, the member was relieved of his work in the hospital and received 
treatment. In these cases, it has been determined that the use of NGS is very beneficial to control 
possible infectious outbreaks and take corrective actions on a clinical level. 
 
Next-generation sequencing to detect resistance genes in infectious diseases. 
NGS still does not have a massive use in hospitals or clinics worldwide due mainly to the high 
cost of this technology, however, it offers many advantages compared to the current 
microbiological analysis specially with the turnaround time and the amount of information about 
the pathogen that you can get it in a single trial. Definitely NGS provides a more complete genome 
data about the pathogens compared with the purely microbiological methods. Two examples of 
highly transmissible diseases with a high incidence in less developed countries, these diseases 
are being studied with the help of NGS, giving very encouraging results that would help to reduce 
their spread and find more suitable treatments for the patient. 
 
Mycobacterium Tuberculosis 
TB is a disease that produces about 1.7 million deaths annually, identifying and deciphering the 
MTBC genotype is imperative to understand human-to-human transmission. Currently the MIRU-
VNR method is used to have a deeper understanding in MTBC sequencing, but it is not very 
useful in regions where this disease is endemic and there is a high rate of conserved genotypes 
(Allix-Beguec, 2008). Nikolayevskyy et al. (2016) analyzed 12 publications and determined that 
NGS performs better discrimination and allows to subdivide clusters, also showed that cut-off 
value of < 6 SNPs between isolates allows to predict a recent TB transmission, additionally, the 
data obtained gives us information about mutant genes that are related to drug resistance and 
that would be very useful in TB diagnosis laboratories.  
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Another study was achieved by Daum et al. (2014) regarded to Pyrazinamide (PZA), this antibiotic 
is part of multidrug antituberculosis therapy and the increase in resistance to this drug has been 
spreading worldwide even though there is a standard drug testing for this compound, when the 
concentrations of resistant organisms are low, the phenotypic testing can give false results that 
are observed after the treatment is started. It was screening 26 isolates multidrug resistance and 
9 of them were PZA resistance. Next generation sequencing was applied to pncA gene and it was 
found that all 9 isolates have an amino acid mutation that could provide PZA resistance. NGS 
appears as the most promising tool to show the gene mutations regarded drug-resistant MTB 
cases. 
 
HIV-1 
It has been determined that HIV-1 positive patients provide evidence that the incidence of 
resistant mutant genes can make treatment with antiretrovirals not very effective. Several studies 
have compared NGS with Sanger sequencing method with the ability to capture minor resistant 
variants in the HIV virus, resulting in NGS identifying more drug-resistant mutations (DRMs), 
almost 50% more compared with the amount of variants found by Sanger Sequencing (Lefterova 
et al., 2015; Simen et al., 2009). Therefore, this fact is important since the existing resistant 
mutations can determine the treatment failure. In many researches carried out it has been shown 
that the quality of analysis with NGS is much higher than Sanger sequencing, which has led to 
the implementation of HIV-1 resistance tests using NGS. 
 
NGS a relevant tool in the development of antibiotics 
It is necessary to take strategies that face AMR, past experiences have indicated that every time 
a novel antibiotic is launched, soon after resistance mechanisms will appear and spread 
worldwide. Functional metagenomics is being used to screen different soil samples from different 
origins and has found novel resistant genes to several antibiotics. The use of metagenomics of 
human microbiome as saliva or gut has also given interesting results to be taken into account in 
the development and testing of novel antibiotics (Crofts et al., 2017). The development of 
antibiotics should not only consider the mechanisms of resistance existing in clinics, but also 
those that exist in the environment. Novel antibiotics in development should be compared against 
a library metagenomics to predict a possible emergence of resistance before it is released to the 
market.  
 
A study by Diaz-Torres et al. (2006) discovered that in the oral microbiome contained genes 
resistant to three antibiotics: tetracycline, gentamycin and amoxicillin. Andries et al., (2005) 
published a research about the use of second generation sequencing technology to find F0 
subunit of the ATP synthase as the target of bedaquiline, which later became the first antibiotic 
approved for TB after 40 years. A resistome study by Cox et al. (2017) screened a small number 
of molecules to find compounds that improve the activity of gentamicin. Of 27 selected 
compounds that presented this activity, two were chosen for a later validation, it was confirmed 
that both of them inhibit aminoglycoside-2 "-O-nucleotidyltransferase (ANT (2 '')-Ia -mediated 
resistance, but if they acted alone they exhibited poor antibiotic activity. Then a screening of the 
combination of the two drugs was carried out and it was possible to find the resistant inhibitor 
genes.  
 
An approach that needs to be investigated in more detail is drug repurposing, this would mean 
giving use to existing antibiotics and directing them in combination to prevent resistance. 
Researchers studied the effect of three β-lactam antibiotics: meropenem, piperacillin, tazobactam 
that, used in combination eliminates the bacteria methicillin-resistant S.aureus (MRSA) N315 in 
vitro and in mouse infection models. In this case, the combined use of these three antibiotics 
totally kills the resistant bacteria without the possibility of a future emergence due to the 
elimination of its resistant gene. 
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NGS for surveillance of antimicrobial resistance 
Current procedures to identify AMR include microbiological analyzes, biochemical methods, that 
consume a lot of time, thus delaying the time to give a quick response to the problem. The spread 
of resistance is a global problem that affects all countries, therefore the monitoring of their 
evolution and dissemination is of vital importance to prevent pandemic diseases. NGS gives us a 
light in the battle against antibiotic resistance genes, performs a rapid analysis of the genome of 
pathogens, providing its characteristics, genotype, antibiotic resistance profiles and other 
important data that help researches to elucidate the risk that could present to global health. 
Willman et al. (2015) carried out an investigation at the University of Tubingen, where two patients 
with ciprofloxacin treatment for six days, presented antibiotic resistance genes (ARGs) in their 
gut, the researchers used metagenomics in order to identify the appearance of these resistance 
genes. These results are useful for clinicians make more precise decisions on antibiotic 
prescriptions that do not have an effect on bacteria in the gut’s patients, and therefore reduce the 
presence of resistant genes. 
 
In the 90s, multidrug-resistance Salmonella Typhimurium DT104 unleashed an epidemic with 
high death rates worldwide. Initially, it was thought that local animals were infecting humans, but 
a WGS analysis of human and livestock samples from Scotland showed that pathogen strains 
were not related, which suggested that imported meat could have been the source of the disease 
(Mather et al., 2013; Koser et al., 2014). 
 
Kluytmans-van den Bergh et al. (2016) performed a study in the University Medical Center 
Groningen (UMCG), highlighting on AMR bacteria. Through the WGS they found the mcr-1 gene 
in three E.Coli strains obtained from chicken meat, although this gene is not present in humans, 
two of these E.Coli strains belonged to a common clone in humans and chickens, called ST117. 
In China there is a monitoring plan that monitors antimicrobial resistance in animals that are bred 
for human consumption, due to this surveillance program was detected the plasmid-borne colistin 
resistance gene, mcr1. This resistant gene endangers the use of colistin in humans, however, its 
detection in an initial phase helped to take action to minimize its diffusion (Du et al., 2016; Crofts 
et al., 2017). 
 
The monitoring of AMR genes in different areas using Next generation sequencing opens a more 
reliable and faster approach to study and detect at an early stage a possible outbreak of resistant 
bacteria. 
 
2. Conclusions 
 
It has reviewed some points related to clinical microbiology and the application of NGS as a tool 
to identify and analyse a pathogen. The great advantage offered by NGS is that we can get a lot 
of data from genome in a single run, being one of the most important feature: antimicrobial 
resistance. It is a promising tool that will revolutionize a future information obtained from 
pathogens that allows to take action in a real-time to avoid infectious outbreaks. However, it is 
necessary to develop at the same time Bioinformatics pipelines (genome assembly, comparative 
genome studies) for the analysis of data, and a metagenomics software that is easy to use so 
that people do not need an exhaustive knowledge of informatics to be able to handle it.  
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